The weekly litigation news digest is live. Subscribe now

IP Verse

Prostaglandin Conjugates And Derivatives For Treating Glaucoma And Ocular Hypertension - EP3206693

The patent EP3206693 was granted to Alcon on Aug 3, 2022. The application was filed on Oct 15, 2015 under application number EP15791399A. The patent is currently recorded with a legal status of "Revoked".

EP3206693

ALCON
Application Number
EP15791399A
Filing Date
Oct 15, 2015
Status
Revoked
Aug 2, 2024
Publication Date
Aug 3, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
STADA ARZNEIMITTELApr 27, 2023HAMM & WITTKOPPADMISSIBLE

Patent Citations (2) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONWO9002124
INTERNATIONAL-SEARCH-REPORTWO2013163219

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents